Raymond Green, DO, FACS

Acute Care Trauma Surgeon, ChristianaCare

Released in October 2019, CRASH-3 is the latest trial exploring the benefits of tranexamic acid, this time in traumatic brain injury. The bottom line: TXA hasn't been shown to reduce mortality.
CHAT NOW
CHAT OFFLINE